Cytek Biosciences annual operating expenses
2020
2021
2022
2023
2024
2025
Cytek Biosciences Operating Expenses Growth & History (CTKB)
Cytek Biosciences's operating expenses was $144.8M for fiscal 2025.
View full Cytek Biosciences company overviewCytek Biosciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $144.8M | $13.2M | +10.04% |
| 2024 | 2024-12-31 | $131.6M | −$5.6M | −4.11% |
| 2023 | 2023-12-31 | $137.3M | $34.5M | +33.56% |
| 2022 | 2022-12-31 | $102.8M | $32.8M | +46.85% |
| 2021 | 2021-12-31 | $70.0M | $31.9M | +83.93% |
| 2020 | 2020-12-31 | $38.1M | — | — |
Cytek Biosciences quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $39.7M | $5.2M | +15.22% |
| Q1 2026 | 2026-03-31 | $39.7M | $4.6M | +13.05% |
| Q4 2025 | 2025-12-31 | $38.5M | $7.8M | +25.47% |
| Q3 2025 | 2025-09-30 | $36.7M | $3.5M | +10.50% |
| Q2 2025 | 2025-06-30 | $34.5M | $528,000 | +1.55% |
| Q1 2025 | 2025-03-31 | $35.1M | $1.4M | +4.10% |
| Q4 2024 | 2024-12-31 | $30.7M | −$2.5M | −7.59% |
| Q3 2024 | 2024-09-30 | $33.3M | −$345,000 | −1.03% |
| Q2 2024 | 2024-06-30 | $34.0M | −$3.3M | −8.92% |
| Q1 2024 | 2024-03-31 | $33.7M | $547,000 | +1.65% |
| Q4 2023 | 2023-12-31 | $33.2M | $3.9M | +13.29% |
| Q3 2023 | 2023-09-30 | $33.6M | $8.1M | +31.75% |
| Q2 2023 | 2023-06-30 | $37.3M | $11.8M | +46.51% |
| Q1 2023 | 2023-03-31 | $33.2M | $10.7M | +47.33% |
| Q4 2022 | 2022-12-31 | $29.3M | $7.0M | +31.23% |
| Q3 2022 | 2022-09-30 | $25.5M | $7.1M | +38.75% |
| Q2 2022 | 2022-06-30 | $25.5M | $9.5M | +59.73% |
| Q1 2022 | 2022-03-31 | $22.5M | $9.2M | +68.74% |
| Q4 2021 | 2021-12-31 | $22.3M | — | — |
| Q3 2021 | 2021-09-30 | $18.4M | $9.5M | +106.40% |
| Q2 2021 | 2021-06-30 | $15.9M | $7.4M | +87.72% |
| Q1 2021 | 2021-03-31 | $13.4M | — | — |
| Q3 2020 | 2020-09-30 | $8.9M | — | — |
| Q2 2020 | 2020-06-30 | $8.5M | — | — |
Cytek Biosciences operating expenses trends
Over the last five fiscal years, Cytek Biosciences's operating expenses increased from $38.1M to $144.8M, a change of $106.8M. The latest reported quarter, Q2 2026, shows $39.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytek Biosciences source filings ↗